Applying results from clinical trials: Tranexamic acid in trauma patients

Journal of Intensive Care

Volumn 2, Issue 1, 2014, Pages

  Roberts, Ian ^a   Prieto Merino, David ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Clinical trials; Evidence based medicine; Generalizability; Tranexamic acid; Trauma

Indexed keywords

TRANEXAMIC ACID;

BLEEDING; CAUSE OF DEATH; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG MECHANISM; HUMAN; INJURY; META ANALYSIS (TOPIC); MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW (TOPIC);

EID: 84979197675     PISSN: None     EISSN: 20520492     Source Type: Journal    
DOI: 10.1186/s40560-014-0056-1     Document Type: Review

References (24)

1. Okamoto S, Okamoto U. Amino-methyl-cyclohexane-carboxylic acid: AMCHA: a new potent inhibitor of fibrinolysis. Keio J Med 1962, 11:105-115. 10.2302/kjm.11.105.
2. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010, 376(9734):23-32. Epub 2010/06/18, 10.1016/S0140-6736(10)60835-5, 20554319.
3. Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011, 377(9771):1096-1101. 101 e1-2. Epub 2011/03/29, 10.1016/S0140-6736(11)60317-6, 21439633.
4. Gruen R, Jacobs I, Reade M. Tranexamic acid and trauma. Med J Aust 2014, 200(5):255. 10.5694/mja13.00023, 24641138.
5. Pusateri A, Weiskopf R, Bebarta V, Butler F, Cestero RF, Chaudry IH, Deal V, Dorlac WC, Gerhardt RT, Given MB, Hansen DR, Hoots WK, Klein HG, Macdonald VW, Mattox KL, Michael RA, Mogford J, Montcalm-Smith EA, Niemeyer DM, Prusaczyk WK, Rappold JF, Rassmussen T, Rentas F, Ross J, Thompson C, Tucker LD. Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities. Shock 2013, 39:121-126. 10.1097/SHK.0b013e318280409a, 23222525.
6. Napolitano LM, Cohen MJ, Cotton BA, Schreiber MA, Moore EE. Tranexamic acid in trauma: how should we use it?. J Trauma Acute Care Surg 2013, 74:1575-1586. 10.1097/TA.0b013e318292cc54, 23694890.
7. Rothman KJ, Gallacher JE, Hatch EE. Why representativeness should be avoided. Int J Epidemiol 2013, 42(4):1012-1014. 10.1093/ije/dys223, 24062287.
8. Doll R, Hill AB. The mortality of doctors in relation to their smoking habits: a preliminary report. Br Med J 1954, 2:1451-1455. 10.1136/bmj.1.4877.1451.
9. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012, 344:e3054. Epub 2012/05/23, 10.1136/bmj.e3054, 22611164.
10. Ker K, Prieto-Merino D, Roberts I: Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss.Br J Surg 2013, doi:10.1002/bjs.9193.
11. Cesarman-Maus G, Hajjar K. Molecular mechanisms of fibrinolysis. Br J Haematol 2005, 129(3):307-321. 10.1111/j.1365-2141.2005.05444.x, 15842654.
12. Lucas M, Fretto L, McKee P. The binding of human plasminogen to fibrin and fibrinogen. J Biol Chem 1983, 258:4249-4256. 6833255.
13. Royal College of Paediatrics Health Child: Major Trauma and the Use of Tranexamic Acid in Children, Evidence Statement. ; 2012. http://www.rcpch. ac.uk/child-health/childrens-medicines/childrens-medicines.
14. Reichenbach H. The Rise of Scientific Philosophy 1951, University of California Press, Bognor Regis, UK.
15. Peto R. Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care. Br J Cancer 2011, 104:1057-1058. 10.1038/bjc.2011.79, 21448174.
16. Roberts I, Perel P, Prieto-Merino D, Shakur H, Coats T, Hunt BJ, Lecky F, Brohi K, Willett K. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial. BMJ 2012, 345:e5839. doi: 10.1136/bmj.e5839, 10.1136/bmj.e5839, 22968527.
17. Protocol 05PRT/1: The CRASH-2 (Clinical Randomization of an Anti-fibrinolytic in Significant Haemorrhage) Trial. .., http://www.thelancet.com/protocol-reviews/05PRT-1
18. Gando S, Sawamura S, Hayakawa M. Trauma, shock, and disseminated intravascular coagulation. Ann Surg 2011, 254:10-19. 10.1097/SLA.0b013e31821221b1, 21368657.
19. Sawamura A, Hayakawa M, Gando S, Kubota N, Sugano M, Wada T, Katabami K. Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality. Thromb Res 2009, 1214:608-613. 10.1016/j.thromres.2009.06.034.
20. Chapman M, Moore E, Ghasabyan A, Harr J, Chin T, Ramos C, Stringham J, Silliman C, Banerjee A. Fibrinolysis above 3% is the critical value for initiation of antifibrinolytic therapy in trauma. J Trauma Acute Care Surg 2013, 75:961-967. 10.1097/TA.0b013e3182aa9c9f, 24256667.
21. Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C, Khan S, De'ath HD, Allard S, Hart DP, Pasi KJ, Hunt BJ, Stanworth S, Maccallums PK, Brohi K. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013, 11:307-314. 10.1111/jth.12078, 23176206.
22. Perel P, Prieto-Merino D, Shakur H, Clayton T, Lecky F, Bouamra O, Russell R, Faulkner M, Steyerberg EW, Roberts I. Predicting early death in patients with traumatic bleeding: development and validation of prognostic model. BMJ 2012, 345:e5166. 10.1136/bmj.e5166, 22896030.
23. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012, 380:581-590. 10.1016/S0140-6736(12)60367-5.
24. Guerriero C, Cairns J, Perel P, Shakur H, Roberts I. Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS One 2011, 6(5):e18987. Epub 2011/05/12, 10.1371/journal.pone.0018987, 21559279.